The March 31 deadline passed without any official announcement or credible reporting of Susie Wiles departing as White House Chief of Staff, driving trader consensus to 100% on "No" as the administration confirmed her continued service. Her early-stage breast cancer diagnosis, publicly disclosed on March 16 amid an excellent prognosis, prompted statements from Wiles and President Trump affirming her full-time role during treatment, quashing speculation. Persistent rumors of post-midterm resignation plans remain unverified and unrelated to the short-term resolution window. While resolved barring late-breaking confirmations of a pre-deadline exit, future shifts could stem from health updates, internal administration pressures, or confirmation hearings for replacements.
Experimental AI-generated summary referencing Polymarket data · Updated$28,874 Vol.
$28,874 Vol.
$28,874 Vol.
$28,874 Vol.
An announcement of Wiles' resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from the Trump administration; however, a consensus of credible reporting may also be used.
Market Opened: Dec 16, 2025, 2:26 PM ET
Resolver
0x65070BE91...Outcome proposed: No
No dispute
Final outcome: No
An announcement of Wiles' resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from the Trump administration; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Outcome proposed: No
No dispute
Final outcome: No
The March 31 deadline passed without any official announcement or credible reporting of Susie Wiles departing as White House Chief of Staff, driving trader consensus to 100% on "No" as the administration confirmed her continued service. Her early-stage breast cancer diagnosis, publicly disclosed on March 16 amid an excellent prognosis, prompted statements from Wiles and President Trump affirming her full-time role during treatment, quashing speculation. Persistent rumors of post-midterm resignation plans remain unverified and unrelated to the short-term resolution window. While resolved barring late-breaking confirmations of a pre-deadline exit, future shifts could stem from health updates, internal administration pressures, or confirmation hearings for replacements.
Experimental AI-generated summary referencing Polymarket data · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions